These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 35719998)
1. Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma. Zhou Z; Xu J; Huang N; Tang J; Ma P; Cheng Y Front Oncol; 2022; 12():855434. PubMed ID: 35719998 [TBL] [Abstract][Full Text] [Related]
2. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma. Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472 [TBL] [Abstract][Full Text] [Related]
3. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma. Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM Front Immunol; 2022; 13():1027794. PubMed ID: 36389690 [TBL] [Abstract][Full Text] [Related]
4. Pyroptosis-Related Gene Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Glioma. Zhang Y; Zhang C; Yang Y; Wang G; Wang Z; Liu J; Zhang L; Yu Y Front Cell Dev Biol; 2022; 10():862493. PubMed ID: 35547808 [No Abstract] [Full Text] [Related]
5. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas. Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y Front Immunol; 2023; 14():1021678. PubMed ID: 36860853 [TBL] [Abstract][Full Text] [Related]
6. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma. Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H Front Immunol; 2022; 13():1013094. PubMed ID: 36466844 [TBL] [Abstract][Full Text] [Related]
7. A novel signature based on necroptosis-related long non-coding RNAs for predicting prognosis of patients with glioma. Xia P; Huang Y; Chen G Front Oncol; 2022; 12():940220. PubMed ID: 36033510 [TBL] [Abstract][Full Text] [Related]
8. A Prognostic Microenvironment-Related Immune Signature Qiu H; Li Y; Cheng S; Li J; He C; Li J Front Oncol; 2020; 10():580263. PubMed ID: 33425732 [TBL] [Abstract][Full Text] [Related]
9. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma. Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X Front Oncol; 2021; 11():682932. PubMed ID: 34123852 [TBL] [Abstract][Full Text] [Related]
10. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
11. A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer. Yu Z; Lu B; Gao H; Liang R J Oncol; 2022; 2022():5643496. PubMed ID: 36425941 [TBL] [Abstract][Full Text] [Related]
12. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis. Wang LJ; Lv P; Lou Y Front Oncol; 2022; 12():862723. PubMed ID: 35574375 [TBL] [Abstract][Full Text] [Related]
13. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q Front Genet; 2022; 13():1053263. PubMed ID: 36712869 [No Abstract] [Full Text] [Related]
14. A pyroptosis-related signature predicts prognosis and indicates immune microenvironment infiltration in glioma. Chen J; Chen S; Li B; Zhou S; Lin H Cancer Med; 2023 Feb; 12(4):5071-5087. PubMed ID: 36161280 [TBL] [Abstract][Full Text] [Related]
15. A Pyroptosis-Related Gene Prognostic Index Correlated with Survival and Immune Microenvironment in Glioma. Zheng J; Zhou Z; Qiu Y; Wang M; Yu H; Wu Z; Wang X; Jiang X J Inflamm Res; 2022; 15():17-32. PubMed ID: 35018108 [TBL] [Abstract][Full Text] [Related]
16. Development and validation of a two glycolysis-related LncRNAs prognostic signature for glioma and in vitro analyses. Xu X; Zhou S; Tao Y; Zhong Z; Shao Y; Yi Y Cell Div; 2023 Jun; 18(1):10. PubMed ID: 37355624 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma. Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432 [TBL] [Abstract][Full Text] [Related]
18. Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma. Zhang G; Chen R; Zhu L; Ma H; Tang H; Shang C; Wang J; Zhang D; Li Q; Liu J Comput Math Methods Med; 2022; 2022():3440586. PubMed ID: 36110575 [TBL] [Abstract][Full Text] [Related]
19. A novel necroptosis-related gene signature associated with immune landscape for predicting the prognosis of papillary thyroid cancer. Wang Z; Wu P; Shi J; Ji X; He L; Dong W; Wang Z; Zhang H; Sun W Front Genet; 2022; 13():947216. PubMed ID: 36186479 [No Abstract] [Full Text] [Related]
20. Construction and validation of an angiogenesis-related gene expression signature associated with clinical outcome and tumor immune microenvironment in glioma. Hu T; Wang Y; Wang X; Wang R; Song Y; Zhang L; Han S Front Genet; 2022; 13():934683. PubMed ID: 36035133 [No Abstract] [Full Text] [Related] [Next] [New Search]